Growth factor-induced expression of macrophage migration inhibitory factor in osteoblasts: Relevance to the plasminogen activator system

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue 6, 1999, Pages 563-568

  Onodera, Shin ^a   Suzuki, Konji ^a   Kaneda, Kiyoshi ^a   Fujinaga, Mami ^b   Nishihira, Jun ^b  

^a Department of Orthopedic Surgery ^*  (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bone tissue remodeling; Growth factor; Macrophage migration inhibitory factor; Osteoblast; Plasminogen activator

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOMATOMEDIN B; TRANSFORMING GROWTH FACTOR BETA; UROKINASE;

ANIMAL CELL; ARTICLE; BONE REMODELING; CELL PROLIFERATION; CELL SYNCHRONIZATION; FLOW CYTOMETRY; GROWTH REGULATION; MACROPHAGE MIGRATION INHIBITION; MOUSE; NONHUMAN; OSTEOBLAST; PATHOPHYSIOLOGY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL;

EID: 0033428232     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994966     Document Type: Article

References (24)

1. Chambers TJ, Darby JA, Fuller K. Mammalian collagenase predispose bone surfaces to osteoclastic resorption. Cell Tissue Res 1985;241:671-675
2. Canalis E, McCarthy T, Centrella M. Growth factors and the regulation of bone remodeling. J Clin Invest 1988;81:277-281
3. Bloom BR, Bennet B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966;153:80-82
4. Shimizu T, Ohkawara A, Nishihira J, Sakamoto W. Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS Lett 1996;381:199-202
5. Wistow GJ, Shaughnessy MP, Lee DC, Hodin J, Zelenka PS. A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc Natl Acad Sci USA 1993;90:1272-1275
6. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ. Distinct proliferation and differentiated stages of murine MC3T3-E1 cells in culture: An in vitro model of osteoblast development. J Bone Min Res 1992;7:683-692
7. Onodera S, Suzuki K, Matsuno T, Kaneda K, Kuriyama T, Nishihira J. Identification of macrophage migration inhibitory factor in murine neonatal calvariae and osteoblasts. Immunology 1996;89:430-435
8. Amarnani S, Merriman HL, Linkhart TA, Baylink DJ, Mohan S. Autocrine regulators of MC3T3-E1 cell proliferation. J Bone Min Res 1993;8:157-165
9. Mohan S, Jennings J, Linkhart T, Taylor A, Baylink D. Purification and characterization of a small molecular weight human skeletal growth factor (hSGF). J Bone Min Res 1986;1:60-66
10. Jennings JC, Mohan S, Baylink DJ. β2-Microglobulin is not a bone cell mitogen. Endocrinology 1989;125:404-409
11. Kasperk C, Wergedal JE, Mohan S, Long DL, Lau KHW, Baylink DJ. Interactions of growth factors present in bone matrix and bone cells: Effects on DNA synthesis and alkaline phosphatase. Growth Factors 1990;3:147-158
12. Globus RK, Plouet J, Gospodarowicz. D. Cultured bovine cells synthesize basic fibroblast growth factor and transforming growth factor beta. Endocrinology 1989;124:1539-1547
13. McCarthy TL, Centrella M, Canalis E. Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. Endocrinology 1989;125:2118-2126
14. Mohan S, Baylink DJ. Bone growth factors. Clin Orthop 1991; 263:30-48
15. Noda M, Rodan GA. Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells. Biochem Biophys Res Commun 1986;140:56-65
16. Uneno S, Yamamoto I, Yamamuro T, et al. Transforming growth factor beta modulates proliferation of osteoblastic cells: Relation to its effect on receptor levels for epidermal growth factor. J Bone Min Res 1989;4:165-171
17. Sherr CJ. Mammalian Gl cyclins. Cell 1993;73:1059-1065
18. Allan EH, Martin TJ. The plasminogen activator inhibitor system in bone cell function. Clin Orthop 1995;313:54-63
19. Cheng SL, Shen V, Peck WA. Regulation of plasminogen activator and plasminogen activator inhibitor production by growth factors and cytokines in rat calvarial cells. Calcif Tissue Int 1991;49:321-327
20. Allan EH, Zeheb R, Gelehter TD, et al. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells. J Cell Physiol 1991;149:34-43
21. Thompson BM, Atkinson SJ, McGarrity AM. Type-I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25 dihydroxyvitamin D3: Evidence for a plasminogen-plasmin-metalloproteinase activation cascade. Biochim Biophys Acta 1989;1014:125-132
22. Rabbani SA, Desjardins J, Bell AW, et al. An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem Biophys Res Commun 1991;173:1058-1064
23. Rabbani SA, Mazar AP, Bernier SM, et al. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J Biol Chem 1992;267:14151-14156
24. Nishibori M, Nakaya N, Mori S, Kawabata M, Tahara A, Saeki K. Affinity purification of macrophage migration inhibitory factor/glycosylation inhibitory factor (MIF/GIF) from bovine brain by using a peptide ligand derived from a novel serpin. Jpn J Pharmacol 1996;71:259-262